Tian Xie

1.3k total citations · 2 hit papers
28 papers, 940 citations indexed

About

Tian Xie is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Tian Xie has authored 28 papers receiving a total of 940 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Tian Xie's work include Nanoplatforms for cancer theranostics (3 papers), BRCA gene mutations in cancer (2 papers) and Surface Modification and Superhydrophobicity (2 papers). Tian Xie is often cited by papers focused on Nanoplatforms for cancer theranostics (3 papers), BRCA gene mutations in cancer (2 papers) and Surface Modification and Superhydrophobicity (2 papers). Tian Xie collaborates with scholars based in China, United States and Switzerland. Tian Xie's co-authors include Renren Bai, Xiang‐Yang Ye, Yuanyuan Xie, Jianan Guo, Xiangang Huang, Wei Chen, Xiaoyuan Ji, Shuying Chen, Wei Tao and Yongjiang Li and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Tian Xie

24 papers receiving 929 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oxidative stress: The core pathogenesis and mechanism of Alzheimer’s disease

2022 489 citations Renren Bai, Jianan Guo et al. Ageing Research Reviews profile →
Nanosensitizer-mediated augmentation of sonodynamic therapy efficacy and antitumor immunity

2023 146 citations Yongjiang Li, Wei Chen et al. Nature Communications profile →

Peers

Countries citing papers authored by Tian Xie

Since Specialization

Citations

This map shows the geographic impact of Tian Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tian Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tian Xie more than expected).

Fields of papers citing papers by Tian Xie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tian Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tian Xie. The network helps show where Tian Xie may publish in the future.

Co-authorship network of co-authors of Tian Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Tian Xie. A scholar is included among the top collaborators of Tian Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tian Xie. Tian Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ciliated cell–derived IL-17D restrains allergic asthma through controlling monocyte recruitment 2025 ·The Journal of Experimental Medicine ·(unknown), Jinling Huang, (unknown), Tian Xie, (unknown), Bowen Xie, (unknown), (unknown), Xuan Zhong, (unknown), Zhilin Peng, Xiaoshuang Wang, (unknown), Jing Ge, (unknown), Chen Dong	1
2	Structure-based design of anticancer drugs based on β-elemene: Research foundations and development potential 2025 ·Journal of Pharmaceutical Analysis ·(unknown), Yuntao Yu, Chenghong Hu, Lingxiao Zhou, Zhe Wang, Odin Zhang, Yi Wang, Tian Xie	0
3	Metal–organic framework–derived zinc oxide–decorated carbon aerogels with aligned lamellar channels and hierarchical roughness for durable superhydrophobic oil–water separation 2025 ·Colloids and Surfaces A Physicochemical and Engineering Aspects ·(unknown), (unknown), (unknown), Tian Xie, Shuduan Deng, (unknown), (unknown), (unknown)	0
4	Modeling and experimentation of surface creation of ultrasonic vibration polishing BK7 optical glasses 2025 ·Journal of Manufacturing Processes ·Chao Zhang, Fanwei Meng, (unknown), Yingdong Liang, Tian Xie, Zhelun Ma, Zixuan Wang, Tianbiao Yu	0
5	Supporting binary metal-organic framework derivatives within wood-based activated carbon boosts rapid adsorption of sulfamethoxazole from aqueous solutions 2025 ·Colloids and Surfaces A Physicochemical and Engineering Aspects ·Jing Wang, (unknown), Zhiping Xu, Qiaowen Chang, Tian Xie, Shuduan Deng, Xianghong Li, (unknown), Kaiqian Li, (unknown)	5
6	A Novel Wind Turbine Pitch Bearing Fault Diagnosis Using Signal Encoding and Attention Mechanism Dual-Channel Parallel Fusion Network 2025 ·IEEE Transactions on Instrumentation and Measurement ·(unknown), (unknown), Tian Xie, (unknown)	0
7	Screening and modification of (+)-germacrene A synthase for the production of the anti-tumor drug (−)-β-elemene in engineered Saccharomyces cerevisiae 2024 ·International Journal of Biological Macromolecules ·Yuhan Hu, Qin Zhang, Xue Bai, (unknown), Jing Ma, (unknown), (unknown), Qiuhui Wei, Rong Chen, Daming Wang, Xiaopu Yin, Tianyuan Hu, Tian Xie	27
8	Nanosensitizer-mediated augmentation of sonodynamic therapy efficacy and antitumor immunity breakdown → 2023 ·Nature Communications ·Yongjiang Li, Wei Chen, Yong Kang, Xueyan Zhen, Zhuoming Zhou, Chuang LIU, Shuying Chen, Xiangang Huang, Haijun Liu, Seyoung Koo, Na Kong, Xiaoyuan Ji, Tian Xie, Wei Tao	146
9	Association of serum 25-hydroxyvitamin D with the incidence of 16 cancers, cancer mortality, and all-cause mortality among individuals with metabolic syndrome: a prospective cohort study 2023 ·European Journal of Nutrition ·(unknown), Junping Guo, Kai Wang, (unknown), Tian Xie, Lin Tao, (unknown)	7
10	Association of sleep duration and noise exposure with hearing loss among Chinese and American adults: two cross-sectional studies 2022 ·BMJ Open ·(unknown), (unknown), Zhaohui Zhu, (unknown), (unknown), (unknown), Tian Xie	8
11	A bidirectional Mendelian randomization study supports the causal effects of a high basal metabolic rate on colorectal cancer risk 2022 ·PLoS ONE ·(unknown), (unknown), Lin Tao, Tian Xie	10
12	Noncausal effects of genetic predicted depression and colorectal cancer risk: A Mendelian randomization study 2022 ·Medicine ·(unknown), (unknown), Tian Xie, Lin Tao	2
13	Oxidative stress: The core pathogenesis and mechanism of Alzheimer’s disease breakdown → 2022 ·Ageing Research Reviews ·Renren Bai, Jianan Guo, Xiang‐Yang Ye, Yuanyuan Xie, Tian Xie	489
14	Establishment of an Ex Vivo Tissue Culture Model for Evaluation of Antitumor Efficacy in Clear Cell Renal Cell Carcinoma 2022 ·Frontiers in Oncology ·Shanjuan Hong, Qing Yuan, (unknown), (unknown), Tiantian Sun, Tian Xie, Zhiyong Zhang, Wei He, Chen Dong, Jian Lü, Li Guo, Ling Ni	8
15	Targeted profiling of polar metabolites in cancer metabolic reprogramming by hydrophilic interaction liquid chromatography-tandem mass spectrometry 2022 ·Journal of Chromatography A ·(unknown), (unknown), (unknown), (unknown), (unknown), Xiaoyu Chen, (unknown), Jianxiang Chen, Xiang Fei, Qi Zhang, Dahong Zhang, Jian‐Liang Zhou, Tian Xie	5
16	Hyperprogression, a challenge of PD-1/PD-L1 inhibitors treatments: potential mechanisms and coping strategies 2022 ·Biomedicine & Pharmacotherapy ·(unknown), (unknown), Die Hu, Haojie Wang, (unknown), (unknown), (unknown), Xin‐Yun Huang, Tian Xie, Jian-Shu Lou	13
17	Genetic risk, incident colorectal cancer, and the benefits of adhering to a healthy lifestyle: A prospective study using data from UK Biobank and FinnGen 2022 ·Frontiers in Oncology ·(unknown), (unknown), Xin Chen, Zhaohui Zhu, (unknown), (unknown), Tian Xie	6
18	Discovery of small-molecule compounds and natural products against Parkinson's disease: Pathological mechanism and structural modification 2022 ·European Journal of Medicinal Chemistry ·(unknown), Xingrui He, Jiamin Ge, Junlong Zhu, Chuansheng Yao, Hong Cai, Xiang‐Yang Ye, Tian Xie, Renren Bai	16
19	PCDH17 Increases the Sensitivity of Colorectal Cancer to 5-Fluorouracil Treatment by Inducing Apoptosis and Autophagic Cell Death 2019 ·SSRN Electronic Journal ·Shuiping Liu, Haoming Lin, (unknown), Qiang� Li, (unknown), Tian Xie, Xinbing Sui	3
20	Study of a new type linear ultrasonic motor with double-driving feet 2006 ·Ultrasonics ·(unknown), Tian Xie, (unknown), Yu Chen	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact